Is NPCE or APYX more profitable?

Apyx Medical has a net margin of -14.78% compared to NeuroPace's net margin of -19.34%. Apyx Medical's return on equity of -76.60% beat NeuroPace's return on equity. Company Net Margins Return on Equity Return on Assets NeuroPace -19.34% -105.64% -16.51% Apyx Medical -14.78% -76.60% -13.91%

Does the media refer more to NPCE or APYX?

In the previous week, Apyx Medical had 1 more articles in the media than NeuroPace. MarketBeat recorded 3 mentions for Apyx Medical and 2 mentions for NeuroPace. NeuroPace's average media sentiment score of 1.17 beat Apyx Medical's score of 1.14 indicating that NeuroPace is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NeuroPace 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Apyx Medical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to APYX or CLPT?

In the previous week, Apyx Medical and Apyx Medical both had 3 articles in the media. ClearPoint Neuro's average media sentiment score of 1.34 beat Apyx Medical's score of 1.14 indicating that ClearPoint Neuro is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Apyx Medical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ClearPoint Neuro 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is APYX or SGHT more profitable?

Apyx Medical has a net margin of -14.78% compared to Sight Sciences' net margin of -35.69%. Sight Sciences' return on equity of -43.39% beat Apyx Medical's return on equity. Company Net Margins Return on Equity Return on Assets Apyx Medical -14.78% -76.60% -13.91% Sight Sciences -35.69% -43.39% -22.86%

Does the media refer more to SI or APYX?

In the previous week, Shoulder Innovations had 7 more articles in the media than Apyx Medical. MarketBeat recorded 10 mentions for Shoulder Innovations and 3 mentions for Apyx Medical. Apyx Medical's average media sentiment score of 1.14 beat Shoulder Innovations' score of 0.62 indicating that Apyx Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Shoulder Innovations 6 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Apyx Medical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer APYX or OFIX?

In the previous week, Apyx Medical had 1 more articles in the media than Orthofix Medical. MarketBeat recorded 3 mentions for Apyx Medical and 2 mentions for Orthofix Medical. Orthofix Medical's average media sentiment score of 1.84 beat Apyx Medical's score of 1.14 indicating that Orthofix Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Apyx Medical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Orthofix Medical 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Apyx Medical (APYX) Competitors

$3.08 +0.08 (+2.67%)

As of 08/28/2026 04:00 PM Eastern

Compare

APYX vs. NPCE, CLPT, SGHT, SI, and OFIX

Should you buy Apyx Medical stock or one of its competitors? Apyx Medical's main competitors and comparable companies include NeuroPace (NPCE), ClearPoint Neuro (CLPT), Sight Sciences (SGHT), Shoulder Innovations (SI), and Orthofix Medical (OFIX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Apyx Medical compare to NeuroPace?

NeuroPace (NASDAQ:NPCE) and Apyx Medical (NASDAQ:APYX) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, analyst recommendations, media sentiment, earnings, dividends and profitability.

Apyx Medical has lower revenue, but higher earnings than NeuroPace. NeuroPace is trading at a lower price-to-earnings ratio than Apyx Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeuroPace	$99.99M	4.95	-$21.47M	-$0.57	N/A
Apyx Medical	$52.84M	2.46	-$11.21M	-$0.20	N/A

In the previous week, Apyx Medical had 1 more articles in the media than NeuroPace. MarketBeat recorded 3 mentions for Apyx Medical and 2 mentions for NeuroPace. NeuroPace's average media sentiment score of 1.17 beat Apyx Medical's score of 1.14 indicating that NeuroPace is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NeuroPace	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Apyx Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

NeuroPace has a beta of 1.92, indicating that its share price is 92% more volatile than the broader market. Comparatively, Apyx Medical has a beta of 1.39, indicating that its share price is 39% more volatile than the broader market.

NeuroPace presently has a consensus target price of $19.29, suggesting a potential upside of 33.84%. Apyx Medical has a consensus target price of $6.60, suggesting a potential upside of 114.29%. Given Apyx Medical's higher probable upside, analysts clearly believe Apyx Medical is more favorable than NeuroPace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeuroPace	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.78
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71

78.8% of NeuroPace shares are held by institutional investors. Comparatively, 55.3% of Apyx Medical shares are held by institutional investors. 19.2% of NeuroPace shares are held by insiders. Comparatively, 15.9% of Apyx Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Apyx Medical has a net margin of -14.78% compared to NeuroPace's net margin of -19.34%. Apyx Medical's return on equity of -76.60% beat NeuroPace's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeuroPace	-19.34%	-105.64%	-16.51%
Apyx Medical	-14.78%	-76.60%	-13.91%

Summary

NeuroPace beats Apyx Medical on 8 of the 15 factors compared between the two stocks.

How does Apyx Medical compare to ClearPoint Neuro?

Apyx Medical (NASDAQ:APYX) and ClearPoint Neuro (NASDAQ:CLPT) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, institutional ownership, dividends, analyst recommendations, valuation and risk.

In the previous week, Apyx Medical and Apyx Medical both had 3 articles in the media. ClearPoint Neuro's average media sentiment score of 1.34 beat Apyx Medical's score of 1.14 indicating that ClearPoint Neuro is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Apyx Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
ClearPoint Neuro	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Apyx Medical has higher revenue and earnings than ClearPoint Neuro. Apyx Medical is trading at a lower price-to-earnings ratio than ClearPoint Neuro, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apyx Medical	$52.84M	2.46	-$11.21M	-$0.20	N/A
ClearPoint Neuro	$36.97M	12.83	-$25.54M	-$1.18	N/A

Apyx Medical has a beta of 1.39, suggesting that its share price is 39% more volatile than the broader market. Comparatively, ClearPoint Neuro has a beta of 1.24, suggesting that its share price is 24% more volatile than the broader market.

55.3% of Apyx Medical shares are owned by institutional investors. Comparatively, 30.1% of ClearPoint Neuro shares are owned by institutional investors. 15.9% of Apyx Medical shares are owned by company insiders. Comparatively, 6.9% of ClearPoint Neuro shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Apyx Medical has a net margin of -14.78% compared to ClearPoint Neuro's net margin of -81.76%. Apyx Medical's return on equity of -76.60% beat ClearPoint Neuro's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apyx Medical	-14.78%	-76.60%	-13.91%
ClearPoint Neuro	-81.76%	-188.09%	-40.88%

Apyx Medical presently has a consensus price target of $6.60, indicating a potential upside of 114.29%. ClearPoint Neuro has a consensus price target of $25.67, indicating a potential upside of 65.06%. Given Apyx Medical's stronger consensus rating and higher possible upside, equities analysts plainly believe Apyx Medical is more favorable than ClearPoint Neuro.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71
ClearPoint Neuro	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

Apyx Medical beats ClearPoint Neuro on 13 of the 15 factors compared between the two stocks.

How does Apyx Medical compare to Sight Sciences?

Apyx Medical (NASDAQ:APYX) and Sight Sciences (NASDAQ:SGHT) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability, media sentiment and analyst recommendations.

In the previous week, Apyx Medical had 2 more articles in the media than Sight Sciences. MarketBeat recorded 3 mentions for Apyx Medical and 1 mentions for Sight Sciences. Sight Sciences' average media sentiment score of 1.61 beat Apyx Medical's score of 1.14 indicating that Sight Sciences is being referred to more favorably in the news media.

Company	Overall Sentiment
Apyx Medical	Positive
Sight Sciences	Very Positive

Apyx Medical has higher earnings, but lower revenue than Sight Sciences. Apyx Medical is trading at a lower price-to-earnings ratio than Sight Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apyx Medical	$52.84M	2.46	-$11.21M	-$0.20	N/A
Sight Sciences	$77.36M	6.09	-$38.43M	-$0.56	N/A

Apyx Medical has a beta of 1.39, indicating that its stock price is 39% more volatile than the broader market. Comparatively, Sight Sciences has a beta of 2.38, indicating that its stock price is 138% more volatile than the broader market.

55.3% of Apyx Medical shares are owned by institutional investors. Comparatively, 55.5% of Sight Sciences shares are owned by institutional investors. 15.9% of Apyx Medical shares are owned by insiders. Comparatively, 30.4% of Sight Sciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Apyx Medical has a net margin of -14.78% compared to Sight Sciences' net margin of -35.69%. Sight Sciences' return on equity of -43.39% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apyx Medical	-14.78%	-76.60%	-13.91%
Sight Sciences	-35.69%	-43.39%	-22.86%

Apyx Medical presently has a consensus price target of $6.60, indicating a potential upside of 114.29%. Sight Sciences has a consensus price target of $7.88, indicating a potential downside of 7.89%. Given Apyx Medical's stronger consensus rating and higher possible upside, research analysts plainly believe Apyx Medical is more favorable than Sight Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71
Sight Sciences	1 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Apyx Medical and Sight Sciences tied by winning 8 of the 16 factors compared between the two stocks.

How does Apyx Medical compare to Shoulder Innovations?

Shoulder Innovations (NYSE:SI) and Apyx Medical (NASDAQ:APYX) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, media sentiment, institutional ownership, dividends, risk and profitability.

Apyx Medical has a net margin of -14.78% compared to Shoulder Innovations' net margin of -58.33%. Shoulder Innovations' return on equity of -23.61% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shoulder Innovations	-58.33%	-23.61%	-19.53%
Apyx Medical	-14.78%	-76.60%	-13.91%

Shoulder Innovations presently has a consensus target price of $25.50, suggesting a potential upside of 21.03%. Apyx Medical has a consensus target price of $6.60, suggesting a potential upside of 114.29%. Given Apyx Medical's stronger consensus rating and higher possible upside, analysts plainly believe Apyx Medical is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shoulder Innovations	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71

55.3% of Apyx Medical shares are held by institutional investors. 29.0% of Shoulder Innovations shares are held by company insiders. Comparatively, 15.9% of Apyx Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Apyx Medical has higher revenue and earnings than Shoulder Innovations. Apyx Medical is trading at a lower price-to-earnings ratio than Shoulder Innovations, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shoulder Innovations	$47.32M	9.27	-$40.36M	-$1.92	N/A
Apyx Medical	$52.84M	2.46	-$11.21M	-$0.20	N/A

In the previous week, Shoulder Innovations had 7 more articles in the media than Apyx Medical. MarketBeat recorded 10 mentions for Shoulder Innovations and 3 mentions for Apyx Medical. Apyx Medical's average media sentiment score of 1.14 beat Shoulder Innovations' score of 0.62 indicating that Apyx Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Shoulder Innovations	6 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Apyx Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Apyx Medical beats Shoulder Innovations on 10 of the 15 factors compared between the two stocks.

How does Apyx Medical compare to Orthofix Medical?

Apyx Medical (NASDAQ:APYX) and Orthofix Medical (NASDAQ:OFIX) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

55.3% of Apyx Medical shares are owned by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are owned by institutional investors. 15.9% of Apyx Medical shares are owned by insiders. Comparatively, 2.7% of Orthofix Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Apyx Medical has higher earnings, but lower revenue than Orthofix Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apyx Medical	$52.84M	2.46	-$11.21M	-$0.20	N/A
Orthofix Medical	$822.31M	0.48	-$92.19M	-$1.54	N/A

Apyx Medical has a beta of 1.39, suggesting that its stock price is 39% more volatile than the broader market. Comparatively, Orthofix Medical has a beta of 0.68, suggesting that its stock price is 32% less volatile than the broader market.

Orthofix Medical has a net margin of -7.41% compared to Apyx Medical's net margin of -14.78%. Orthofix Medical's return on equity of -14.05% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apyx Medical	-14.78%	-76.60%	-13.91%
Orthofix Medical	-7.41%	-14.05%	-7.17%

Apyx Medical presently has a consensus price target of $6.60, indicating a potential upside of 114.29%. Orthofix Medical has a consensus price target of $14.75, indicating a potential upside of 52.06%. Given Apyx Medical's stronger consensus rating and higher probable upside, research analysts clearly believe Apyx Medical is more favorable than Orthofix Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71
Orthofix Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

In the previous week, Apyx Medical had 1 more articles in the media than Orthofix Medical. MarketBeat recorded 3 mentions for Apyx Medical and 2 mentions for Orthofix Medical. Orthofix Medical's average media sentiment score of 1.84 beat Apyx Medical's score of 1.14 indicating that Orthofix Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Apyx Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Orthofix Medical	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Apyx Medical beats Orthofix Medical on 10 of the 16 factors compared between the two stocks.

Get Apyx Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding APYX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

APYX vs. The Competition

Export

Metric	Apyx Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$129.74M	$5.82B	$7.20B	$12.90B
Dividend Yield	N/A	1.75%	2.54%	11.28%
P/E Ratio	N/A	25.92	273.16	25.45
Price / Sales	2.46	67.80	640.71	89.43
Price / Cash	N/A	33.03	76.74	53.00
Price / Book	7.90	6.18	12.98	6.14
Net Income	-$11.21M	$149.01M	$3.48B	$348.86M
7 Day Performance	-1.28%	-0.24%	0.13%	-0.80%
1 Month Performance	-25.24%	6.18%	7.08%	4.13%
1 Year Performance	54.77%	6.30%	24.67%	15.17%

Apyx Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
APYX Apyx Medical	3.2851 of 5 stars	$3.08 +2.7%	$6.60 +114.3%	+54.8%	$129.74M	$52.84M	N/A	270	Positive News
NPCE NeuroPace	3.496 of 5 stars	$14.47 +1.3%	$19.29 +33.3%	+57.5%	$506.97M	$99.99M	N/A	170	Positive News
CLPT ClearPoint Neuro	2.3795 of 5 stars	$15.18 -2.1%	$25.67 +69.1%	+48.2%	$467.93M	$36.97M	N/A	110	Positive News
SGHT Sight Sciences	1.6974 of 5 stars	$8.22 -0.2%	$7.88 -4.2%	+110.6%	$448.42M	$77.36M	N/A	210
SI Shoulder Innovations	2.538 of 5 stars	$21.09 +5.9%	$23.50 +11.4%	+41.2%	$431.58M	$47.32M	N/A	61

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:APYX) was last updated on 8/30/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Apyx Medical (APYX) Competitors

APYX vs. NPCE, CLPT, SGHT, SI, and OFIX

How does Apyx Medical compare to NeuroPace?

Summary

How does Apyx Medical compare to ClearPoint Neuro?

Summary

How does Apyx Medical compare to Sight Sciences?

Summary

How does Apyx Medical compare to Shoulder Innovations?

Summary

How does Apyx Medical compare to Orthofix Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

APYX vs. The Competition

Apyx Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Apyx Medical (APYX) Competitors

APYX vs. NPCE, CLPT, SGHT, SI, and OFIX

How does Apyx Medical compare to NeuroPace?

Which has better valuation & earnings, NPCE or APYX?

Does the media refer more to NPCE or APYX?

Which has more volatility & risk, NPCE or APYX?

Do analysts recommend NPCE or APYX?

Do insiders & institutionals believe in NPCE or APYX?

Is NPCE or APYX more profitable?

Summary

How does Apyx Medical compare to ClearPoint Neuro?

Does the media refer more to APYX or CLPT?

Which has stronger earnings and valuation, APYX or CLPT?

Which has more risk & volatility, APYX or CLPT?

Do institutionals & insiders have more ownership in APYX or CLPT?

Is APYX or CLPT more profitable?

Do analysts recommend APYX or CLPT?

Summary

How does Apyx Medical compare to Sight Sciences?

Does the media prefer APYX or SGHT?

Which has higher valuation and earnings, APYX or SGHT?

Which has more volatility and risk, APYX or SGHT?

Do insiders & institutionals believe in APYX or SGHT?

Is APYX or SGHT more profitable?

Do analysts rate APYX or SGHT?

Summary

How does Apyx Medical compare to Shoulder Innovations?

Is SI or APYX more profitable?

Do analysts rate SI or APYX?

Do insiders and institutionals believe in SI or APYX?

Which has better valuation and earnings, SI or APYX?

Does the media refer more to SI or APYX?

Summary

How does Apyx Medical compare to Orthofix Medical?

Do institutionals & insiders believe in APYX or OFIX?

Which has preferable valuation and earnings, APYX or OFIX?

Which has more risk & volatility, APYX or OFIX?

Is APYX or OFIX more profitable?

Do analysts prefer APYX or OFIX?

Does the media prefer APYX or OFIX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

APYX vs. The Competition

Apyx Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools